SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Beryl Drugs - Quaterly Results

12 Feb 2024 Evaluate
The sales for the December 2023 quarter moved down to Rs. 76.60 millions as compared to Rs. 81.90 millions during the year-ago period.Net Profit for the quarter ended December 2023 zoomed to 116.78% from Rs. 1.43 millions to Rs. 3.10  millions.OP of the company witnessed a marginal growth to 7.96 millions from 7.15 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 76.60 81.90 -6.47 239.16 210.63 13.55 271.57 147.69 83.88
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 7.96 7.15 11.33 26.49 19.40 36.55 22.14 5.73 286.39
Interest 1.13 1.17 -3.42 3.30 3.55 -7.04 4.16 4.37 -4.81
PBDT 6.83 5.98 14.21 23.19 15.85 46.31 17.98 1.36 1222.06
Depreciation 3.08 2.20 40.00 8.85 6.61 33.89 8.14 10.86 -25.05
PBT 3.75 3.78 -0.79 14.34 9.24 55.19 9.84 -9.50 -203.58
TAX 0.65 2.35 -72.34 3.17 2.21 43.44 2.18 -2.91 -174.91
Deferred Tax -0.46 2.35 -119.57 -1.94 2.21 -187.78 0.58 -3.00 -119.33
PAT 3.10 1.43 116.78 11.17 7.03 58.89 7.66 -6.59 -216.24
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 10.39 8.73 19.03 11.08 9.21 20.26 8.15 3.88 110.13

Beryl Drugs Share Price

24.52 -0.52 (-2.08%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×